Literature DB >> 14206016

STREPTOKINASE AND PULMONARY EMBOLISM.

N L BROWSE, D C JAMES.   

Abstract

Keywords:  AMINOCAPROIC ACID; BLOOD COAGULATION TESTS; CLINICAL RESEARCH; DOGS; EXPERIMENTAL LAB STUDY; FIBRINOLYSIS; HEPARIN; INJECTIONS, INTRAVENOUS; ISOTONIC SOLUTIONS; PHENINDIONE; POSTOPERATIVE COMPLICATIONS; PULMONARY EMBOLISM; STREPTODORNASE AND STREPTOKINASE; THROMBOPHLEBITIS

Mesh：

Substances：

Year:  1964        PMID： 14206016     DOI： 10.1016/s0140-6736(64)90991-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  13 in total

1.  Treatment of pulmonary embolism with fibrinolytic agents.

Authors:  E E Cliffton
Journal:  Bull N Y Acad Med       Date:  1967-04

Review 2.  Deep vein thrombosis.

Authors:  G E Mavor
Journal:  Postgrad Med J       Date:  1971-05       Impact factor: 2.401

3.  Management of pulmonary embolism.

Authors: 
Journal:  Br Med J       Date:  1968-10-19

4.  Thrombolytic therapy.

Authors: 
Journal:  Br Med J       Date:  1968-12-21

5.  Deep-vein thrombosis.

Authors: 
Journal:  Br Med J       Date:  1966-09-03

6.  Pulmonary embolectomy.

Authors: 
Journal:  Br Med J       Date:  1967-12-09

Review 7.  Pulmonary embolism: current therapeutic concepts.

Authors:  D A Tibbutt; C N Chesterman
Journal:  Drugs       Date:  1976       Impact factor: 9.546

8.  Streptokinase therapy in acute major pulmonary embolism: effectiveness and problems.

Authors:  J Hirsh; G S Hale; I G McDonald; R A McCarthy; A Pitt
Journal:  Br Med J       Date:  1968-12-21

9.  Treatment of pulmonary embolism with streptokinase. A preliminary report.

Authors:  G A Miller; R V Gibson; M Honey; G C Sutton
Journal:  Br Med J       Date:  1969-03-29

10.  Resolution of experimental pulmonary emboli with heparin and streptokinase in different dosage regimens.

Authors:  J Hirsh; J F Cade; E Regoeczi; M Gent; M R Buchanan; D M Hynes
Journal:  J Clin Invest       Date:  1974-10       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.